Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
cholesterol
2
×
ldl
life sciences
national blog main
national top stories
new york
new york blog main
new york top stories
amarin
amgen
attack
biotech
boston blog main
boston top stories
cardiovascular
clinical trials
data
david maron
diabetes
eicosapentaenoic acid
fish oil
heart disease
inclisiran
john thero
lovaza
mark timney
mineral oil
mt sinai hospital
omacor
pcsk9
peter wijngaard
praluent
prashant vaishnava
reduce-it
regeneron pharmaceuticals
repatha
san francisco blog main
san francisco top stories
sanofi
stroke
What
big
2
×
abuzz
aces
ago
amarin
announced
ceo
cholesterol
clinical
community
deeper
dive
doctors
drug
eager
fish
flexible
gives
inclisiran
key
lowering
meant
medco
medical
medicine
medicines
months
nasdaq
oil
open
passed
ponder
prescription
pricing
reduce
risk
showed
study
supplement
taken
Language
unset
Current search:
cholesterol
×
big
×
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
Deeper Dive: Amarin Fish-Oil Study Gives Eager Doctors More to Ponder
